NCT02151162

Brief Summary

The study is to explore the effectiveness of omega-3 fatty acids and mindfulness-based stress management program to maintain healthy mental state in hospital nurses. The participants will be junior nurses who work in inpatient wards and are not clinically depressed. The participants will be randomly allocated to four intervention arms: 1) Mindfulness-based stress management program plus omega-3 fatty acids pills ; 2) Mindfulness-based stress management program plus placebo pills; 3) Psychoeducation leaflet plus omega-3 fatty acids pills; and 4) Psychoeducation leaflet plus placebo pills. Thirty participants will be allocated to each arm. These interventions will terminate until three months from registration for each participant. Information about depression and anxiety symptoms (primary outcome), insomnia, burnout, presenteeism, quality of life, sick leave, consultation about mental state of herself, and oxidative stress will be collected at 3 months, 6 months (primary time point) and 12 months from registration for each participant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2014

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 30, 2014

Completed
12 days until next milestone

Study Start

First participant enrolled

June 11, 2014

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2016

Completed
Last Updated

August 22, 2018

Status Verified

August 1, 2018

Enrollment Period

1.7 years

First QC Date

May 27, 2014

Last Update Submit

August 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)

    The total score of the HADS (HADS-T) ranges from 0 to 42, with higher scores indicating more symptoms. The HADS has two sub scores, each ranging from 0 to 21: HADS-D (depression) and HADS-A (anxiety). The total score will be used as the severity of depression and anxiety symptoms in the present study.

    26 weeks

Secondary Outcomes (26)

  • Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)

    13 weeks

  • Blindly-rated depression and anxiety severity: Hospital Anxiety and Depression Scale (HADS)

    52 weeks

  • Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)

    26 weeks

  • Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)

    13 weeks

  • Major depressive episode: Primary Care Evaluation of Mental Disorders (PRIME-MD)

    52 weeks

  • +21 more secondary outcomes

Other Outcomes (1)

  • Adverse events

    13 weeks

Study Arms (4)

Stress management plus omega-3

EXPERIMENTAL

Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.

Behavioral: Mindfulness-based stress management programDietary Supplement: Omega-3 fatty acids pills

Stress management plus placebo

ACTIVE COMPARATOR

Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.

Behavioral: Mindfulness-based stress management programDietary Supplement: Placebo pills

Psychoeducation leaflet plus omega-3

ACTIVE COMPARATOR

Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.

Dietary Supplement: Omega-3 fatty acids pillsBehavioral: Psychoeducation leaflet

Psychoeducation leaflet plus placebo

ACTIVE COMPARATOR

Thirty participants will be allocated to the arm. These interventions will terminate until 3 months from registration for each participant.

Behavioral: Psychoeducation leafletDietary Supplement: Placebo pills

Interventions

Mindfulness-based stress management program will be conducted by senior nurses in four individual sessions within these three months. Senior nurses have taken a 7-hour workshop including lectures and role-playing sessions. The detailed manual and videos including lectures will be provided to the senior nurses.

Stress management plus omega-3Stress management plus placebo
Omega-3 fatty acids pillsDIETARY_SUPPLEMENT

Omega-3 fatty acids pills will include 1200 mg of eicosapentaenoic acid and 600 mg of docosahexaenoic acid per day.

Psychoeducation leaflet plus omega-3Stress management plus omega-3

Psychoeducation leaflet will include information about screening of stress, sleep hygiene, relaxation, and a list of consultants about mental health.

Psychoeducation leaflet plus omega-3Psychoeducation leaflet plus placebo
Placebo pillsDIETARY_SUPPLEMENT

Placebo pills will include rapeseed oil, soybean oil, olive oil and fish oil.

Psychoeducation leaflet plus placeboStress management plus placebo

Eligibility Criteria

Age20 Years - 59 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Work for inpatient wards in among four general hospitals in Tama region, Japan, including: National Center of Neurology and Psychiatry Hospital, National Disaster Medical Center, Tokyo Metropolitan Tama Medical Center, and Tama-Hokubu Medical Center
  • Nurses without administration work
  • Give written consent in the participation of the study

You may not qualify if:

  • Have plans to take sick leave, leave for other reasons or retirement within 26 weeks from the entry to the study
  • Take structured psychotherapy (e.g. cognitive behavioral therapy, interpersonal therapy, and brief psychodynamic therapy) at the entry
  • See a physician regularly in order to treat any mood or anxiety disorders primarily at the entry
  • Take antidepressants, mood stabilizers, anticonvulsants or antipsychotics at the entry
  • Have taken nutrient supplement including omega-3 fatty acids for 4 or more weeks within 52 weeks from the entry
  • Clinically depressed, based on the total score of 11 or more on the Hospital Anxiety and Depression Scale - Depression Subscale and the total score of 15 or more on the Primary Health Care Questionnaire
  • Consume 4 times or more of fish as the main course of meal per week
  • Take anticoagulant drugs at the entry or have previous history of stroke or myocardial infarction
  • Judged ineligible by research coordinator due to any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National Center of Neurology and Psychiatry

Kodaira, Tokyo, 187-8551, Japan

Location

Kyoto University

Kyoto, 606-8501, Japan

Location

Related Publications (3)

  • Kunzler AM, Helmreich I, Chmitorz A, Konig J, Binder H, Wessa M, Lieb K. Psychological interventions to foster resilience in healthcare professionals. Cochrane Database Syst Rev. 2020 Jul 5;7(7):CD012527. doi: 10.1002/14651858.CD012527.pub2.

  • Watanabe N, Horikoshi M, Shinmei I, Oe Y, Narisawa T, Kumachi M, Matsuoka Y, Hamazaki K, Furukawa TA. Brief mindfulness-based stress management program for a better mental state in working populations - Happy Nurse Project: A randomized controlled trial✰✰. J Affect Disord. 2019 May 15;251:186-194. doi: 10.1016/j.jad.2019.03.067. Epub 2019 Mar 22.

  • Watanabe N, Furukawa TA, Horikoshi M, Katsuki F, Narisawa T, Kumachi M, Oe Y, Shinmei I, Noguchi H, Hamazaki K, Matsuoka Y. A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses (Happy Nurse Project): study protocol for a randomized controlled trial. Trials. 2015 Jan 31;16:36. doi: 10.1186/s13063-015-0554-z.

MeSH Terms

Conditions

Depressive DisorderAnxiety Disorders

Condition Hierarchy (Ancestors)

Mood DisordersMental Disorders

Study Officials

  • Norio Watanabe, MD, PhD

    Kyoto University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2014

First Posted

May 30, 2014

Study Start

June 11, 2014

Primary Completion

March 2, 2016

Study Completion

September 6, 2016

Last Updated

August 22, 2018

Record last verified: 2018-08

Locations